Financial Information

KemPharm® is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products.

Financial Information

Filing date Form Description Filing Group View
8-K

Report of unscheduled material events or corporate event

Current Reports
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
SC 13G/A

An amendment to the SC 13G filing

Other
View HTML
SC 13G/A

An amendment to the SC 13G filing

Other
View HTML
424B3

Form of prospectus reflecting facts events constituting substantive change from last form

Registration Statements
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
424B3

Form of prospectus reflecting facts events constituting substantive change from last form

Registration Statements
View HTML
SC 13D

Filing by person(s) reporting owned shares of common stock in a public company >5%

Other
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML